Peptide Decoding
New?New to peptides?Start here →
Decoding

Retinalamin_Dosage, benefits & legal status

Also known as retinalamine, retina polypeptide extract

Published August 24, 2026 · Updated October 4, 2026

A Russian retina extract given by injection, from the same tradition as Cortexin.

Eyes & agingTissue peptide extractResearch only
Common vial size5 mg
Dose5 up to 10 mg per day
FrequencyDaily, in 10-day courses
RouteInto a muscle
StatusResearch only
CycledNo established pattern

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Retinalamin?

Plain language first. The technical label stays, but it never stands alone.

Overview

An injectable extract of cow retina used in Russian eye clinics. Not approved anywhere in the West, and eyes are a poor place to experiment.

The technical version

A polypeptide fraction extracted from bovine retinal tissue, administered intramuscularly, registered and used in the Russian Federation for retinal and optic nerve pathology. No single defined sequence. No controlled efficacy data published outside the originating literature.

What it's used for

Used in Russian ophthalmology for retinal conditions including diabetic retinopathy and glaucoma-related nerve damage. Not approved in the US, Europe or the UK.

02

How does Retinalamin work?

What it does in the body, and where.

Retinalamin is a mixture rather than a single molecule, which shapes what can be said about it.

  1. 01
    It is an extract, not a defined peptide
    Drawn from bovine retinal tissue and containing many fragments. There is no single sequence and most components have never been characterized.
  2. 02
    The proposed action is on retinal cells
    Russian sources describe effects on photoreceptor function and retinal metabolism. These are mechanism proposals rather than results from controlled trials.
  3. 03
    It sits alongside Visoluten in a confusing way
    Visoluten is the oral Khavinson retinal Cytomax. Retinalamin is a separate injectable preparation from a different tradition. Both are bovine retinal extracts and they are not the same product.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Diabetic retinopathy, in Russian clinical practicenone
  • Optic nerve damage and glaucoma support, in Russian clinical practicenone
  • Age-related retinal degenerationnone

The published record

Research index

27

Papers and trials about Retinalamin

19 papers tagged human · 17 not reviews or lab · 4 clinical trial publications

Furthest stage reached: Approved outside the US, Russia

Compare this against the whole library →

In animals5
In the lab1
Reviews1
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

Retinalamin vial rendering
Compound field notes

At a glance

Four things to know about Retinalamin

01

Evidence

Research only

02

Category

Healing and recovery

03

Common vial

5 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

5 up to 10 mg per day, daily, in 10-day courses. No established pattern No range

No published human study establishes a schedule.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No pharmacokinetic data has been published for this preparation. As a mixture of unidentified fragments, a single half-life would not be meaningful in any case.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 5 up to 10 mgClinical use

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW100 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Retinalamin keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • A known allergy to bovine products
  • Any eye condition, where an unstudied extract is not a substitute for ophthalmic care

Stop and get help

These are emergencies. Seek care.
  • Any change in vision
  • Any allergic reaction

Common effects

Expected, and usually mild.
  • No controlled safety data is available outside Russian clinical use.
  • Injectable animal tissue extracts carry an immune-reaction risk that oral versions do not.

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Retinalamin approved?

And where the numbers on this page come from.

Not in the United States. Retinalamin has no FDA approval and is sold there labeled for laboratory research only, so there is no legal route to buy it for human use. It is approved in Russia.

  • Approval status
    Research only
  • Route
    Into a muscle
  • Checked
    20 September 2026
  • Approved outside the US
    Russia: Registered in Russia as a prescription medicine made by Geropharm, registration LS-000684. Not approved in the US or EU.This does not change the United States position above.
  • Dose
    From product labeling and clinical guidelines.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 27 records are indexed. Browse the records